Combination nivolumab- and cabiralizumab-associated acute bilateral anterior and posterior scleritis and anterior uveitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination nivolumab- and cabiralizumab-associated acute bilateral anterior and posterior scleritis and anterior uveitis

Published:2018-06 Issue: Volume:10 Page:117-118
ISSN:2451-9936
Container-title:American Journal of Ophthalmology Case Reports
language:en
Short-container-title:American Journal of Ophthalmology Case Reports

Author:

Gonzales John A.,Shantha Jessica,Acharya Nisha R.

Funder

National Institutes of Health - National Eye Institute Career Development Award

National Eye Institute

Research to Prevent Blindnessew York, NY

Publisher

Elsevier BV

Subject

Ophthalmology

Reference5 articles.

1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

2. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab;Abu Samra;Eur J Ophthalmol,2016

3. Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: case report;Basilious;Can J Ophthalmol,2016

4. A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma;Hanna;Pharmacotherapy,2016

5. Bilateral anterior uveitis associated with nivolumab therapy;Karlin;Ocul Immunol Inflamm,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular adverse events associated with immune checkpoint inhibitors, a scoping review;Journal of Ophthalmic Inflammation and Infection;2023-02-22

2. Ocular Inflammation Induced by Immune Checkpoint Inhibitors;Journal of Clinical Medicine;2022-08-25

3. The Rise in Immunotherapy and Associated Ocular Toxicities;Global Perspectives in Ocular Oncology;2022

4. Pharmacologically induced uveitis;Survey of Ophthalmology;2021-09

5. Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review;Seminars in Ophthalmology;2021-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3